Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mahmoud M. Mubarek has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Isolation of New Secondary Metabolites from Kedrostis gijef and Evaluation of Their α-Glucosidase Inhibitory Activity

    by Kuniyoshi Shimizu, Mahmoud Mubarek, Fahd M. Abdelkarem, Ahmed Othman, Fangjing Li, Masako Matsumoto

    Four new polyoxygenated cucurbitane triterpene glycosides named kedrojiftene A-D (4-7), were isolated via different chromatographic techniques along with three phenolic compounds (1-3) from the crude extract of Kedrostis gijef. The isolated compounds were elucidated based on 1D, 2D-NMR spectroscopic analyses, HRESIMS and comparison with the related metabolites in literature. In bioassay, the α-glucosidase inhibitory assay for the isolated compounds was carried out and compounds (1-3) showed significant inhibitory activities.


  • Isolation of two new cucurbitane-type triterpenoids from Kedrostis gijef

    by Mahmoud M. Mubarek, Ahmed Othman, Fahd M. Abdelkarem, Kuniyoshi Shimizu

    Two new cucurbitane-type triterpenoids (2,3), together with two known compounds (1,4), were isolated from the aerial parts of Kedrostis gijef. The structure of all compounds was elucidated based on NMR, HRESIMS analyses, and by comparison with the literature. Additionally, the cytotoxic activity against HeLa, Caco-2, and SH-SY5Y cell lines was determined using MTT colorimetric assay.

  • In vivo antidiabetic potential of standardized Gymnocarpos decandrus Forssk. Extract

    by Seham S. El-Hawary, Mahmoud M. Mubarek, Rehab A. Lotfy, Amany A. Sleem, Mona M. Okba

    Background Gymnocarpos decandrus (Caryophyllaceae) is a well-known wild plant used as a food for grazing animals. Recently it showed potent antidiabetic potential beside its established anti-inflammatory, analgesic and diuretic activities. G. decandrus antidiabetic potential was reported through in-vitro models and resulted in promising α-amylase, α-glucosidase and antiviral Coxsackie B4 inhibitory activities; however no in-vivo studies were conducted. Purpose This study aims to examine Gymnocarpos decandrus ethanol extract (GDEE) safety and to evaluate its in vivo antidiabetic potential. Method Adult albino rats were injected intraperitoneally with alloxan to induce diabetes mellitus and the glucose level was measured after two and four weeks against metformin as a standard drug. Additionally, GDEE characterization and standardization were carried out. Results GDEE LD50 was up to 5.8 mg/kg and exhibited significant antidiabetic activity 77.17% comparable to the standard drug metformin. Its total phenolics, and flavonoids amounted 127.2 ± 0.23 and 85.5 ± 0.21 mg/g respectively. Vitexin was used as a marker compound for GDEE (140.70 mg/100 gm). Conclusion This study represents the sole in vivo scientific validation of G. decandrus recently documented in vitro antidiabetic potential.


  • Validation of Antidiabetic Potential of Gymnocarpos decandrus Forssk

    by Seham S. El-Hawary, Mahmoud M. Mubarek, Rehab A. Lotfy, Ahmed R. Hassan, Mansour Sobeh, Mona M. Okba

    Gymnocarpos decandrus Forssk. is a well-known grazing wild plant. This study targets scientific validation of its claimed antidiabetic activity and exploring its bioactive metabolites. Chromatographic purification of G. decandrus ethanol extract (GDEE) allowed isolation of vitexin (C1), protocatechuic acid (C2) and quercetin (C3). HPLC-PDA-MS/MS enabled identification of nineteen metabolites; 13 flavonoids, 5 saponins, and 1 phenolic acid in G. decandrus and four in the genus Gymnocarpos for the first time. The antidiabetic potential was evaluated via testing the Coxsackie B4 virus and α-glucosidase inhibitory potentials. C3 exhibited its potent antiviral activity through blocking of the virus attachment (96.28%, SI 4.41) and virus inactivation before adsorption (91.47%, SI 4.78). GDEE and C1–C3 showed dose dependent α-glucosidase inhibitory activity with IC50 of 733.9, 293.3, 118.1 and 69.1 µg/mL, respectively. Our study represents the sole complete map for G. decandrus secondary metabolites and presents it as promising drug for diabetes management.


    • 14 December 2019

    A Botanical Study and Estimation of Certain Primary Metabolites of Gymnocarpos decandrus Forssk

    by Mahmoud Mubarek, Mona M. Okba, Rehab A. Lotfy, Mahmoud M. Mubarek